Table 1.
SCCS stroke cohort demographics and medical history.
| All RAO (N = 16,193) | CRAO (N = 6577) | BRAO (N = 9616) | |
|---|---|---|---|
|
Age mean (SD) |
74.6 (8.4) | 75.4 (8.3) | 74.1 (8.4) |
| Race | |||
| White | 11,638 (71.9%) | 4662 (70.9%) | 6976 (72.5%) |
| Asian | 408 (2.5%) | 143 (2.2%) | 265 (2.8%) |
| Black | 1475 (9.1%) | 669 (10.2%) | 806 (8.4%) |
| Hispanic | 1228 (7.6%) | 512 (7.8%) | 716 (7.4%) |
| Unknown | 1444 (8.9%) | 591 (9.0%) | 853 (8.9%) |
| Gender (female) | 8201 (50.6%) | 3354 (51.0%) | 4847 (50.4%) |
| Cong. heart failure | 3780 (23.3%) | 1698 (25.8%) | 2082 (21.7%) |
| Myocardial infarction | 2828 (17.5%) | 1225 (18.6%) | 1603 (16.7%) |
| Arrhythmia | 5807 (35.9%) | 2506 (38.1%) | 3301 (34.3%) |
| Atrial fib/flutter | 3110 (19.2%) | 1365 (20.8%) | 1745 (18.1%) |
| Hypertension | 14,063 (86.8%) | 5788 (88.0%) | 8275 (86.1%) |
| Diabetes mellitus | 6525 (40.3%) | 2741 (41.7%) | 3784 (39.4%) |
| Transient ischaemic attack | 2298 (14.2%) | 988 (15.0%) | 1310 (13.6%) |
| Chronic liver disease | 163 (1.0%) | 69 (1.0%) | 94 (1.0%) |
| Chronic pulmonary disease | 6501 (40.1%) | 2674 (40.7%) | 3827 (39.8%) |
| Peripheral vascular disease | 5837 (36.0%) | 2487 (37.8%) | 3350 (34.8%) |
| Any malignancy | 3576 (22.1%) | 1500 (22.8%) | 2076 (21.6%) |
| Chronic kidney disease | |||
| – No | 9388 (58.0%) | 3603 (54.8%) | 5785 (60.2%) |
| – Any chronic kidney disease | 2093 (12.9%) | 933 (14.2%) | 1160 (12.1%) |
| – End-stage renal disease | 4712 (29.1%) | 2041 (31.0%) | 2671 (27.8%) |
| Stroke (during study periods only) | 1756 (10.8%) | 787 (12.0%) | 969 (10.1%) |